Advantage Austria Show navigation

Biotrinity 2017

Biotrinity 2017 logo
21. December 2016

The major biopartnering and investment conference returns to London

Austrian companies have been a regular feature of the Biotrinity conference for several years now, so we look forward to seeing what innovative life science and medical technologies will be represented at the 2017 event.

Returning once again to the Novotel London West, the Biotrinity event takes place from 8-10 May 2017. It is billed as Europe's leading biopartnering and investment conference, and takes the form of an exhibition combined with a packed presentation programme and the all-important one-two-one partnering sessions.

The latter provides a unique opportunity for companies, research institutions and investors to meet each other in a series of highly-focused meetings, which are arranged in advance through an online system. In 2016, over 2,500 such meetings took place.

Presentations and workshops, meanwhile, span biotech, advanced therapies, medtech and platform technology at all stages of development, and there is also an opportunity to hear individual company presentations and enjoy several large networking receptions - all providing more opportunities to make valuable new contacts. Over a thousand delegates from some 30 countries did so in 2016, representing companies ranging from young startups to the biggest pharmaceutical multinationals.

For more information on this year's event, visit the Biotrinity website . Alternatively, for information on Austrian participants, contact Monika Dunkel in our London office.

Related links

 
Biotrinity website
print
©©ADVANTAGE AUSTRIA